Child-Adult Atopic Dermatitis Research Trial 2 (13 Weeks)

Individuals aged 2 years and older with a clinical diagnosis of atopic dermatitis (AD), may qualify to participate. Must have moderate to severe disease, with AD covering 5 – 35% body surface area (excluding the scalp). AD present for at least 6 months for ages 6 years old and above or 3 months for ages 2 to 5 years old, is also required.

Participants will receive investigational topical medication (active study drug) or placebo, via a cream. Study medication and study-related procedures will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last about 13 weeks and involve about 7 visits to the study centre, plus 2 phone visits.

Call the study centre near you, or register now.

Learn more about
Atopic Dermatitis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more